These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31403951)

  • 1. Does Vitamin D reduce disease activity in people with multiple sclerosis? A Cochrane Review summary with commentary.
    Engkasan JP
    NeuroRehabilitation; 2019; 45(1):135-136. PubMed ID: 31403951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of rehabilitation interventions for people with multiple sclerosis - A Cochrane Review summary with commentary.
    Amatya B; Khan F; Galea M
    NeuroRehabilitation; 2019; 45(3):429-431. PubMed ID: 31796692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do non-pharmacological interventions improve chronic pain in multiple sclerosis? - A Cochrane Review summary with commentary.
    Amatya B; Young J; Khan F
    NeuroRehabilitation; 2019; 45(2):291-293. PubMed ID: 31498133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are exercise interventions beneficial for people with hip and knee osteoarthritis? - A Cochrane Review summary with commentary.
    Ilieva EM
    Musculoskelet Sci Pract; 2019 Dec; 44():102041. PubMed ID: 31377189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How effective are treatments for anxiety after stroke? - A Cochrane Review summary with commentary.
    Knapp P
    NeuroRehabilitation; 2019; 44(3):457-458. PubMed ID: 31177247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the effects of strength training and aerobic exercise training for muscle disease? - A Cochrane Review summary with commentary.
    Afridi A; Rathore FA
    J Rehabil Med; 2021 Sep; 53(9):jrm00231. PubMed ID: 34559242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is multidisciplinary biopsychosocial rehabilitation effective on pain, disability, and work outcomes in adults with subacute low back pain? A Cochrane Review summary with commentary.
    Oral A
    Musculoskelet Sci Pract; 2019 Dec; 44():102065. PubMed ID: 31622862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D for the management of multiple sclerosis.
    Jagannath VA; Fedorowicz Z; Asokan GV; Robak EW; Whamond L
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008422. PubMed ID: 21154396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of vitamin D in neurological diseases and neurorehabilitation: from dementia to multiple sclerosis. Part I: the role of vitamin D in the prevention and treatment of multiple sclerosis].
    Speer G
    Ideggyogy Sz; 2013 Sep; 66(9-10):293-303. PubMed ID: 24358684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Vitamins and Dietary Supplements by Patients With Multiple Sclerosis: A Review.
    Evans E; Piccio L; Cross AH
    JAMA Neurol; 2018 Aug; 75(8):1013-1021. PubMed ID: 29710293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D and multiple sclerosis—from epidemiology to prevention.
    Sundström P; Salzer J
    Acta Neurol Scand; 2015; 132(199):56-61. PubMed ID: 26046560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
    Faridar A; Eskandari G; Sahraian MA; Minagar A; Azimi A
    Acta Neurol Belg; 2012 Dec; 112(4):327-33. PubMed ID: 22767049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does time spent in rehabilitation make a difference on activity limitation and impairment in people with stroke? - A Cochrane Review summary with commentary.
    Gimigliano F
    J Rehabil Med; 2022 Aug; 54():jrm00315. PubMed ID: 35980003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. If I had CIS with MRI diagnostic of MS, I would take vitamin D 10,000 IU daily: Commentary.
    Hutchinson M
    Mult Scler; 2013 Feb; 19(2):143-4. PubMed ID: 23388851
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.
    James E; Dobson R; Kuhle J; Baker D; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Oct; 19(12):1571-9. PubMed ID: 23698130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology.
    Brum DG; Comini-Frota ER; Vasconcelos CC; Dias-Tosta E
    Arq Neuropsiquiatr; 2014 Feb; 72(2):152-6. PubMed ID: 24604370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fat-soluble vitamins as disease modulators in multiple sclerosis.
    Torkildsen Ø; Løken-Amsrud KI; Wergeland S; Myhr KM; Holmøy T
    Acta Neurol Scand Suppl; 2013; (196):16-23. PubMed ID: 23190287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of vitamin D in multiple sclerosis.
    Brown SJ
    Ann Pharmacother; 2006 Jun; 40(6):1158-61. PubMed ID: 16684809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
    Jelinek GA; Marck CH; Weiland TJ; Pereira N; van der Meer DM; Hadgkiss EJ
    BMC Neurol; 2015 Aug; 15():132. PubMed ID: 26243188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and multiple sclerosis: can vitamin D prevent disease progression?
    Mehta B; Ramanathan M; Weinstock-Guttman B
    Expert Rev Neurother; 2011 Apr; 11(4):469-71. PubMed ID: 21469917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.